Impact of COVID-19 on quality checks of solid tumor molecular diagnostic testing-A surveillance by EQAS provider in India

Background Molecular tests in solid tumours for targeted therapies call for the need to ensure precision testing. To accomplish this participation in the External Quality Assessment Program (EQAS) is required. This evaluates the consistency of diagnostic testing procedures and offers guidance for im...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2022-09, Vol.17 (9), p.e0274089-e0274089
Hauptverfasser:	Shetty, Omshree, Shet, Tanuja, Iyer, Ramya, Gogte, Prachi, Gurav, Mamta, Joshi, Pradnya, Karnik, Nupur, Pai, Trupti, Epari, Sridhar, Desai, Sangeeta
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Cancer Care and treatment Control Coronaviruses COVID-19 COVID-19 diagnostic tests Diagnosis Diagnostic tests Digital imaging Disease transmission Epidemics Evaluation Human resource management India Laboratories Medical care Medical diagnosis Medicine and Health Sciences Molecular diagnostic techniques Oncology Pandemics Participation Polls & surveys Quality assessment Quality assurance Quality control Quality management Reagents Research and Analysis Methods Safety measures Severe acute respiratory syndrome coronavirus 2 Skills Solid tumors Surveys Test procedures Testing laboratories Testing procedures Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!